MedPath

To evaluate the Safety and efficacy of two Unani formulations in the treatment of overactive bladder.

Phase 2
Conditions
Health Condition 1: N329- Bladder disorder, unspecifiedHealth Condition 2: null- Zof-e-Masana (Overactive Bladder)
Registration Number
CTRI/2013/12/004258
Lead Sponsor
Central Council for Research in Unani Medicine CCRUM New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

1.Age- more than 18 yrs and upto 65 yrs

2.Gender- both

3.History of the following symptoms for more than six months

•Urgency of urine

•Incontinence

•Dysuria

Exclusion Criteria

Patients with Bladder calculus

2.Patients withUrinary tract infections

3.Patients with Benign Prostrate Hypertrophy

4.Patients with Uterine prolapse

5.Patients with Rectocele/cystocele

6.Patients with Cystitis

7.Patients with Diabetes Mellitus

8.Patients with Hypertension

9.Pregnant and lactating females

10.Neoplasm

11.Patients with Hepatic/Cardiac diseases

12.Medications (anticholinergic, antidepressant, psychotropic, or alpha-blocker)

13.Patients with History of any Spinal cord injury

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath